Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

215
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
215
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

127
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
127
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

162
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
162
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

290
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
290
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

207
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
207
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

791
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
791

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Growth Differentiation Factor-15 Could Predict Decreased Hemoglobin in Tuberculosis Treated With Linezolid-Containing Regimen.

The clinical respiratory journal·2026
Same author

The ghost of tuberculosis past.

Nature medicine·2026
Same author

Lungs Are Only Half the Story: Programmatic Shifts to Prioritize Pediatric Extrapulmonary Tuberculosis Detection in High-Burden Settings.

Journal of the Pediatric Infectious Diseases Society·2026
Same author

Tuberculosis infection tests for contact screening in Brazil: a cost-effectiveness analysis.

Lancet regional health. Americas·2026
Same author

Age and sex differences in paediatric tuberculosis care for child contacts.

Journal of global health·2026
Same author

Diagnostic Performance of New Commercial IGRAs for Mycobacterium tuberculosis Infection: An updated Systematic Review and Meta-analysis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
查看所有相关文章

相关实验视频

Updated: May 23, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K

结核病

Anete Trajman1, Jonathon R Campbell2, Tenzin Kunor3

  • 1Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; McGill International TB Centre, Montreal, QC, Canada.

Lancet (London, England)
|March 8, 2025
PubMed
概括
此摘要是机器生成的。

结核病是一个全球性的健康威胁. 早期诊断和以个人为中心的全面护理,包括管理风险因素和并发症,对于有效治疗和预防这种空气传播疾病至关重要.

更多相关视频

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.0K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

13.8K

相关实验视频

Last Updated: May 23, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.7K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.0K
A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

13.8K

科学领域:

  • 全球健康
  • 传染性疾病
  • 呼吸系统医学

背景情况:

  • 结核病仍然是全球死亡的一个重要原因.
  • 空气传播对所有人构成风险,特别是在高发病率地区.
  • 由于营养不良,免疫抑制和糖尿病等并发症等因素,

研究的目的:

  • 审查目前关于结核病传播,诊断,治疗和预防的认识.
  • 强调以个人为中心的治疗对结核病及其相关风险因素的重要性.
  • 强调对结核病的诊断和治疗进行持续研究的必要性.

主要方法:

  • 对结核病流行病学,临床表现和管理策略的当前文献的审查.
  • 分析诊断方法,包括唾液检查,分子测试和胸部放射.
  • 检查治疗方案,预防方法以及管理并发症和社会决定因素的作用.

主要成果:

  • 结核病的诊断需要高度的怀疑指数,并通过唾液测试和X射线扫描进行迅速的鉴定.
  • 有效的治疗包括对耐药结核病的短期治疗方案 (≤6个月),对耐药结核病的更长时间治疗方案.
  • 针对营养不良,吸毒以及糖尿病和艾滋病毒等并发症的综合治疗对于成功的结果和预防长期并发症至关重要.

结论:

  • 结核病的成功治疗取决于早期诊断,量身定制的治疗,以及以个人为中心的整体护理.
  • 对于有效控制和预防结核病,应对社会决定因素和相关疾病至关重要.
  • 诊断和治疗方面的进展,以及改善的预防策略,对于实现全球结核病消除至关重要.